Astrazeneca Pharma India Ltd.

4752.75 -102.35 ▼-2.1%

08 December 2023, 04:01:00 PM
Volume: 862

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.astrazenecaindia.com/india
Market Cap 11,877.38 Cr.
Enterprise Value(EV) 11,357.12 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 61.12 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 77.73 Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share 261.99 Trailing Twelve Months Ending 2023-09
Price to Book Value 18.13 Calculated using Price: 4,750.95
Dividend Yield 0.34 Period Ending 2023-03
No. of Shares Subscribed 2.50 Cr. 25,000,000 Shares
FaceValue 2
About Astrazeneca Pharma India Ltd.
The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. AstraZeneca Pharma India is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC.

Astrazeneca Pharma India Ltd. Delivery

Delivered Qty
Traded Qty

Astrazeneca Pharma India Ltd. Performance

1 Day
-2.11%
1 Week
-0.14%
1 Month
+0.18%
3 Month
+10.68%
6 Month
+36.25%
1 Year
+42.44%
2 Year
+53.36%
5 Year
+251.21%
10 Year
+470.35%

Astrazeneca Pharma India Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -12.93 3.43 10.63 11.12 20.03 21.83 22.83 12.78 18.13
Return on Capital Employed (%) -12.93 3.76 18.74 18.65 26.53 34.61 31.24 17.36 24.49
Return on Assets (%) -5.04 1.25 4.25 4.76 9.34 10.57 11.31 6.65 9.37

Astrazeneca Pharma India Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 151 156 223 247 301 364 456 511 589 655
Non Curr. Liab. 1 39 89 110 23 44 45 74 69 -10
Curr. Liab. 260 234 202 219 268 367 373 392 484 435
Minority Int.
Equity & Liab. 412 429 514 575 591 776 874 977 1,142 1,081
Non Curr. Assets 148 162 250 243 178 193 186 212 206 127
Curr. Assets 263 267 263 333 413 582 689 765 936 954
Misc. Exp. not W/O
Total Assets 412 429 514 575 591 776 874 977 1,142 1,081

Astrazeneca Pharma India Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 517 564 544 571 728 832 814 806 1,003 1,141
Other Income 8 7 14 12 16 13 13 15 26 32
Total Income 525 571 558 583 745 845 826 820 1,029 1,173
Total Expenditure -531 -547 -507 -525 -657 -711 -678 -719 -838 -925
PBIDT -6 23 51 59 88 134 148 101 191 248
Interest -1 -1 -1 -1 -1
Depreciation -15 -17 -16 -15 -15 -19 -20 -17 -16 -16
Taxation -1 -15 -18 -18 -42 -34 -21 -35 -55
Exceptional Items -40 -24
PAT -21 5 20 26 54 72 93 62 99 153
Adjusted EPS -8 2 8 10 22 29 37 25 40 61

Astrazeneca Pharma India Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -46 57 38 9 55 87 105 101 58
Cash Fr. Inv. -15 -19 -4 0 -9 4 -171 173 5 18
Cash Fr. Finan. 86 -1 -6 -9 -9 -24
Net Change 71 -64 53 38 -1 59 -90 269 96 52
Cash & Cash Eqvt 88 23 76 115 114 173 84 352 448 500

Astrazeneca Pharma India Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Astrazeneca Pharma India Ltd. Announcements

Sat, 02 Dec 2023
Astrazeneca Pharma India Limited Receives Permission To Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For BREZTRI AEROSPHERE
This is to inform you that AstraZeneca Pharma India Limited has received permission to import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drugs Standard Control Organisation for Budesonide Ph. Eur 160 mg + Glycopyrronium Ph. Eur 7.2 mcg + Formoterol Fumarate Dihydrate Ph. Eur 5 mcg inhalation preparations (BREZTRI AEROSPHERE).
Fri, 01 Dec 2023
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Appointment Of Senior Management Personnel
Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we wish to inform you that based on the recommendation of Nomination and Remuneration Committee the Board of Directors of the Company has approved the appointment of Mr. Venkat Natarajan as Lead - Market Access with effect from January 2 2024.
Tue, 21 Nov 2023
Astrazeneca Pharma India Limited Receives Permission To Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Additional Indication Of Olaparib (Lynparza)
AstraZeneca Pharma India Limited receives permission to import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from Central Drug Standard Control Organisation for the additional indication of Olaparib (Lynparza).

Astrazeneca Pharma India Ltd. Technical Scans

Fri, 08 Dec 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 6 Months High Increase in 6 Months

Astrazeneca Pharma India Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,444.27 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,508.23 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.51 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.97 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Astrazeneca Pharma India Ltd. FAQ's

What is Astrazeneca Pharma I share price?

Can I buy Astrazeneca Pharma I shares now?

What is the Dividend Yield of Astrazeneca Pharma I?

What is the Market Cap of Astrazeneca Pharma I?

What are the key metrics to analyse Astrazeneca Pharma I?

What is the 52 Week High and Low of Astrazeneca Pharma I?

What is the trend of Astrazeneca Pharma I share price?